|
Factors
|
5 year DFS rate (%)
|
Univariate
|
Multivariate
|
|---|
| | |
HR (95% CI)
|
P
|
HR (95% CI)
|
P
|
|---|
|
Menopause
| | |
0.065
| | |
|
Yes
|
100
|
1
| | | |
|
No
|
75.4
|
0.183 (0.024–1.391)
| | | |
|
Surgery
| | |
0.003
| |
0.032
|
|
Staging
|
93.8
|
1
| |
1
| |
|
Unstaged
|
70.6
|
4.95 (1.557–15.792)
| |
3.883 (1.123–13.430)
| |
|
Stage
| | |
0.971
| | |
|
IC1
|
76.9
|
1
| | | |
|
IC2-IC3
|
80.8
|
1.019 (0.368–2.819)
| | | |
|
Adjuvant chemotherapy
| | |
0.197
| | |
|
No
|
76.3
|
1
| | | |
|
Yes
|
87.5
|
0.517 (0.186–1.433)
| | | |
|
Initial treatment
| | |
0.038
|
0.345
|
0.345
|
|
Our clinical
|
91.9
|
1
| |
1
| |
|
Outer
|
72.2
|
2.984 (1.012–8.799)
| |
1.747 (0.549–5.562)
| |
|
Lymph node dissection
| | |
0.386
| | |
|
Yes
|
87.8
|
1
| | | |
|
No
|
76.1
|
1.578 (0.557–4.472)
| | | |
- AGCT: adult granulosa cell tumor; DFS: disease-free survival
